HOSPITAL UNIVERSITARIO RUBER
Departamento
Instituto de Estudios Catalanes
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Estudios Catalanes (1)
2024
-
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2733-2743